PATENT CLAIM ANALYSIS

Application Number: 16412091
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "210210"]

Abstract:
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Claim (Index 3):
A method for inhibiting KRas G12C activity in a cell, comprising contacting the cell in which inhibition of KRas G12C activity is desired with an effective amount of a compound of according to any one of  claim 1  or  2 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 100.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15814279', '16191190', '16173726', '13586814', '13948342']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8004218168613051
- 35 USC 102 Novelty (BERT): 0.6119022784844232
- Combined Prediction Score: 0.7815698630236169
- Mean Citation Score: 450.776984
- Max Citation Score: 570.5313
- Similarity Product: 511.5591120028853

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test